Skip to main content
See every side of every news story
Published • loading... • Updated

Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals

Summary by CNBC
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.

5 Articles

CNBCCNBC
+2 Reposted by 2 other sources
Lean Left

Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals

Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.

·Englewood Cliffs, United States
Read Full Article

As the list of drugs that will lose their patent protection at the beginning of the next decade expands, multinationals in the industry are also looking for new treatments in China.… Big Pharma: Turning to China for new drugs before the patent “wall” - ΙΝΑΦΤΕΜΟΠΟΡΙΚΙ

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
34% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CNBC broke the news in Englewood Cliffs, United States on Friday, October 2, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal